Toxin assay is more reliable than ICD-9 data and less time-consuming than chart review for public reporting of Clostridium difficile hospital case rates
Journal of Hospital Medicine, 03/23/2012Welker JA et al.
A positive C. difficile toxin assay accurately reports the institutional incidence of disease and is more reliable than ICD–9 query. This process can be instituted at a fraction of the cost of the standard chart review, and enables governmental agencies to inexpensively add Clostridium difficile–associated disease to their list of reportable diseases.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.